Literature DB >> 34558487

Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity?

Amitav Banerjee1, Bhargav Gaikwad2, Atul Desale2, Sudhir Laxman Jadhav3, Hetal Rathod3, Kajal Srivastava4.   

Abstract

BACKGROUND: COVID-19 is a public health concern currently demanding continuous efforts to understand its epidemiology. Pimpri-Chinchwad township with a population of over 25 lakhs is located in Maharashtra, one of the worst affected states in India. After the incidence peaked in the township in mid-September 2020, cases started declining even as lockdown restrictions were eased.
OBJECTIVES: A seroprevalence study was conducted to understand the transmission dynamics of the pandemic in this region.
METHODS: We carried out a population-based seroprevalence study for IgG antibodies for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) among 5000 residents 12 years and above selected by the cluster random sampling. We selected 50 clusters in slums, 80 clusters in tenements, and 70 clusters from housing societies. The field work for collection of samples was carried out from October 07 to October 17, 2020. We used kit from Abbott (SARS-CoV-2 IgG), which employs chemiluminescent microparticle immunoassay technology. The prevalence of IgG antibodies was expressed as point estimates with 95% confidence intervals (CIs). These were weighted for areas and cluster effect and further adjusted for test performance.
RESULTS: The overall seropositivity for IgG was 34.04% (95% CIl 31.3%-36.8%). Slum dwellers had 40.9% positivity rate (95% CI 37.0%-44.7%), those in tenements 41.2% (95% CI 37.7%-44.8%) and people living in housing societies had 29.8% positivity (95% CI 25.8%-33.8%).
CONCLUSION: A considerable proportion of population had encountered the novel coronavirus approaching partial, if not complete, herd immunity, which may partly explain the declining trend in spite of easing of lockdown restrictions.

Entities:  

Keywords:  Herd immunity; India; Maharashtra; seroprevalence IgG

Mesh:

Substances:

Year:  2021        PMID: 34558487     DOI: 10.4103/ijph.IJPH_122_21

Source DB:  PubMed          Journal:  Indian J Public Health        ISSN: 0019-557X


  4 in total

1.  Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications.

Authors:  Andrew T Levin; Nana Owusu-Boaitey; Sierra Pugh; Bailey K Fosdick; Anthony B Zwi; Anup Malani; Satej Soman; Lonni Besançon; Ilya Kashnitsky; Sachin Ganesh; Aloysius McLaughlin; Gayeong Song; Rine Uhm; Daniel Herrera-Esposito; Gustavo de Los Campos; Ana Carolina Pecanha Peçanha Antonio; Enyew Birru Tadese; Gideon Meyerowitz-Katz
Journal:  BMJ Glob Health       Date:  2022-05

2.  COVID-19 Serological Survey-3 Prior to Second Wave in Mumbai, India.

Authors:  Gajanan D Velhal; Jayanthi S Shastri; Daksha Shah; Sachee R Agrawal; Mangala Gomare; Deepika Mandar Sadawarte
Journal:  Indian J Community Med       Date:  2022-03-16

3.  Population-based repeat cross-sectional seroprevalence survey of SARS-CoV-2 IgG antibodies in Pimpri Chinchwad Municipal Corporation Area, Maharashtra, India.

Authors:  Mukesh S Bawa; Atul V Desale; Harshal T Pandve; Abhijit V Nimbalkar; Tushar V Patil; Laxman P Gophane; Abhaychandra A Dadewar; Pandurang Thatkar; Shivaji T Dhage; Medha K Kharat; Shailaja M Bhavsar; Rajendra P Firke; Vijaya A Ambedkar; Sunita S Salve; Trupti M Sagale
Journal:  J Family Med Prim Care       Date:  2022-06-30

4.  Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study.

Authors:  Dinesh Kumar; Meena Sidhu; Sandeep Dogra; Bhupinder Kumar; Bhavna Sahni; Arvind Kumar Yadav; Kiran Bala; Rashmi Kumari; Richa Mahajan; Shalli Bavoria; Anuradha Kalotra; Sachin Gupta
Journal:  Indian J Med Res       Date:  2022-01       Impact factor: 5.274

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.